Prescient Therapeutics (ASX:PTX) Tax Rate % : 0.00% (As of Dec. 2023)

View and export this data going back to 1986. Start your Free Trial

What is Prescient Therapeutics Tax Rate %?

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Prescient Therapeutics's Tax Expense for the six months ended in Dec. 2023 was A$0.00 Mil. Prescient Therapeutics's Pre-Tax Income for the six months ended in Dec. 2023 was A$-3.62 Mil. Therefore, Prescient Therapeutics's Tax Rate % for the quarter that ended in Dec. 2023 was 0.00%.

Prescient Therapeutics Tax Rate % Historical Data

The historical data trend for Prescient Therapeutics's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prescient Therapeutics Tax Rate % Chart

Prescient Therapeutics Annual Data

Trend

Jun13

Jun14

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Tax Rate %

Get a 7-Day Free Trial

Prescient Therapeutics Semi-Annual Data
	Dec13	Jun14	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Tax Rate %	Get a 7-Day Free Trial															-	-	-	-	-

Prescient Therapeutics Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Prescient Therapeutics's Tax Rate % for the fiscal year that ended in Jun. 2023 is calculated as

Tax Rate %	=	Tax Expense (A: Jun. 2023 )	/	Pre-Tax Income (A: Jun. 2023 )
	=	0	/	-7.005
	=	0.00 %

Prescient Therapeutics's Tax Rate % for the quarter that ended in Dec. 2023 is calculated as

Tax Rate %	=	Tax Expense (Q: Dec. 2023 )	/	Pre-Tax Income (Q: Dec. 2023 )
	=	0	/	-3.619
	=	0.00 %

Prescient Therapeutics Tax Rate % Related Terms

Thank you for viewing the detailed overview of Prescient Therapeutics's Tax Rate % provided by GuruFocus.com. Please click on the following links to see related term pages.

Prescient Therapeutics (ASX:PTX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Prescient Therapeutics Ltd (ASX:PTX) » Definitions » Tax Rate %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Level 4, 100 Albert Road, South Melbourne, Melbourne, VIC, AUS, 3205

Website

https://www.ptxtherapeutics.com

Prescient Therapeutics Ltd is a clinical-stage oncology company. The company develops novel compounds for the treatment of a range of cancers in Australia. Its product in the pipeline includes OmniCAR; PTX-100 and PTX-200. OmniCAR is a universal immune receptor platform enabling controllable T-cell activity and multi-antigen targeting with a single cell product.

Prescient Therapeutics (ASX:PTX) Headlines

No Headlines